In this setting, there is likely to be apoptosis and fibrosis, while low expression of PPARα and NR1H4TGFβ activates the SMAD3-mediated TGFβ pathway, leading to the progression of BA and cirrhosis. This evidence concerns the gene SMAD3 and breast angiosarcoma.